Articles

Expert perspectives on clinical trials, regulatory strategy, and therapeutic area insights from the aCROss Medical team.

Orthobiologics
Enrollment Done Right: How Collaborative Site Networks Exceed What Individual Effort Cannot
Behind every breakthrough therapy is a race against time. We made sure this one won - for a UK MedTech company's clinical trial, turning ambitious targets into a success story.
Medical Device Orthopedics Case Study
Read →
Acute Stroke
Running a Global Acute Stroke Trial: Lessons from the ImpACT-24B Study
Inside the operational reality of BrainsGate's pivotal ImpACT-24B trial - 1,000+ patients, 73 centers, 18 countries, and what true 24/7 activation readiness actually requires from a CRO.
Neurology Stroke Case Study
Read →
Ophthalmology
Ophthalmology Clinical Trials: Why Sponsors Choose aCROss Vision
Physician-led ophthalmology CRO services across Georgia, Armenia, Israel, and Uzbekistan. A deep look at why leading device and pharma sponsors partner with aCROss Vision - from faster regulatory timelines to treatment-naive patient access across key indications.
Glaucoma Cornea Retina
Read →
Company News
aCROss Medical at LSI Europe '25
Our Chief Medical Officer, Yoram Solberg, MD, PhD, presented aCROss Medical at the LSI Europe '25 Emerging Medtech Summit in London. Watch the full talk.
Company News Events
Read →
Regulatory Affairs
Artificial Intelligence in Clinical Development: What FDA and EMA Expect in 2026
How emerging FDA and EMA guidance is shaping the use of AI in clinical research and regulatory submissions - from the AIM-NASH DDT qualification to governance frameworks that every biotech and MedTech company needs to understand.
FDA EMA AI
Read →